|
Past Weekly
Updates
|
- May 6, 2014
- April 30, 2014
- April 22, 2014
- April 15, 2014
- April 8, 2014
- March 31, 2014
- March 24, 2014
- March 18, 2014
- March 11, 2014
- March 3, 2014
- Feb 21st, 2014
- Feb 14, 2014
- Feb 7, 2014
- Jan 31, 2014
- Jan 21. 2014
- Jan 14, 2014
|
|
Recent SoCalBio Members
| |
Laragen (Culver City)
Laragen, Inc. was founded in 1995 with the sole intention of providing the highest quality DNA sequencing and genotyping in the industry. The company's primary goals are to provide impeccable quality, fast DNA sequencing and genotyping services for academic institutions as well as private companies ... Learn more
SetPoint Medical (Valencia)
SetPoint Medical is a medical device company seeking to treat patients with debilitating inflammatory diseases, such as Crohn's Disease and rheumatoid arthritis, using proprietary implantable neuromodulation devices ... Learn more
BioVinc (Culver City)
BioVinc offers the new fluorescent molecular probes targeting bone, based on technology developed by Professor Charles E. McKenna at the University of Southern California ... Learn more
Biolase specialize in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients .. Learn more
ADRx (Thousand Oaks)
ADRx, Inc. is a biopharmaceutical company created to develop first-in-class and best-in-class drugs for amyloid diseases. The company intends to discover and develop drug candidates independently and in partnertnership with pharmaceutical and biotechnology companies ...
Biotechnical Services Inc. (San Diego)
Provides scientific lab equipment sales and services, such as calibration and validation.... Learn more
Response Genetics (Los Angeles)
Response Genetics is a publicly traded biotech company focused on developing molecular diagnostic assays to help determine the patient's response to cancer therapies ... Learn More
Pharmacos Biopharmaceutical Services (Irvine)
Pharmacos services small to mid-size specialty biopharmaceutical and medical device companies by providing a complete suite of outsourcing and/or consulting services which support drug development, registration, commercialization, life cycle management and commercial operations ..
CRB USA (Carlsbad)
CRB is a global design, construction and consulting firm that services the bioscience and other advanced technology industries. The firm employs over 600 people in 10 offices serving clients throughout the world ... Learn More
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
| Cut Cost of Business |
Enjoy Significant Discounts on Lab Supplies and Instruments
Available only to SoCalBio members in Southern California
In collaboration with BIO, SoCalBio offers member companies in Southern California preferential pricing and complimentary services on lab supplies and instruments offered by VWR. SoCalBio members utilizing this program save on averge about 47% off the list price ... Learn more
|
|
New Financing
|
 | | Christian Behrenbruch, PhD, CEO, ImaginAB |
Inglewood, Calif.-Based ImaginAB Raises $21 Million in Venture Funding
UCLA spinoff and Momentum Biosciences' alumnus ImaginAb has concluded a $21 million venture deal to advance its antibody-re-engineering technology, a biotech approach to imaging that the company believes will help personalize treatments for cancer and immune disease. Mérieux Développement, Novartis, Cycad Group and Nextech Invest are among the investors.... Read more
Kudos to Chris and his crew at ImaginAB
|
|
NDA
|
Calabasas-Based KYTHERA Biopharmaceuticals Submits New Drug Application for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat
 "Since we began evaluating ATX-101 through our global clinical development program, it has demonstrated positive results in reducing fat under the chin, paired with an excellent safety profile and high patient satisfaction," said Frederick Beddingfield, III (photo right) ,M.D., Ph.D., chief medical officer, KYTHERA. "We feel that ATX-101 has the opportunity to address a true unmet need in the U.S. aesthetic marketplace. We are excited to submit this new drug application for the FDA's review". ... Read press release
|
|
Ophthalmic
|
Irvine-Based AcuFocus Makes a Bid for Premarket Approval of its Kamra Device
 MassDevice reports that an FDA panel will meet on June 6 to discuss AcuFocus' premarket approval application for its Kamra Inlay system, a ring-shaped inlay inserted underneath the cornea. The company is seeking to have the device approved for use in improving vision for patients with presbyopia who need intermediate or near vision correction ...Read more
|
|
Register Now
| |
SoCalBio Workshop on Accessing
Government Funding
Attend this SoCalBio Workshop to to get more information about new SBIR/STTR and other grant funding opportunities. This workshop will also sharpen your grant-writing skills and help you tap various government funding opportunities from the NIH and DoD.
Speakers
- Patricia Weber, DrPH, Program Director, SBIR Development Center, National Cancer Institute, NIH
- David Hood, MS, MBA, PMP, President and CEO, DH3 & Associates, {Former Senior Advisor to Principal Assistant for Acquisition US Army MRMC}
- Melissa Harman, Partner, Moss Adams
- Terence Doherty, Director of Interdisciplinary Research, LA BioMed
Other Upcoming Events
|
|
Competition
|
Enter the 2014 MedTech Innovator Competition for $100k Prize
 RCT Ventures has just announced a new opportunity for early-stage medical device companies: the 2014 MedTech Innovator competition. Companies and university-stage teams are encouraged to apply. Ten semi-finalists will be selected by a panel of medical device venture capitalists that will receive free registration to the Wilson Sonsini Medical Device conference. There, a live audience will select the winner, who will receive the $100k grand prize... Click here to apply
|
|
Emerging Markets
|
China Relaxes its Drug Price Controls
Reuters reports that "Under the new policy announced by the price regulator, over 500 drugs considered to be essential for public health will now be officially classified as "low-priced" drugs and sold for standard rates. Prices will be capped at 3 yuan ($0.48) per daily dosage for Western drugs, and 5 yuan for traditional Chinese medicine.
Previously, China set individual price caps for over 2,000 drugs covered by national health insurance".... Read more
|
|
Digital Health
|
Medtronic Executive Dr. Stephen Oesterle Thinks Google Will Be a Force to Be Reckoned with in the Medical Technology Space in Coming Years
 MassDevice quoted Dr Oesterle who said "We spend $1.5 billion a year on R&D at Medtronic - and it's mostly D," he said. "Google is spending $8 billion a year on R&D and, as far as I can tell, it's mostly R." Oesterle pointed to Google's recently revealed "smart" contact lens project as evidence of the Palo Alto-based tech behemoth's interest in medtech ... Read more
|
|
Join the SoCalBio Digital Health Group
|
This is a sub-group of the Southern California Biomedical Council (SoCalBio) on LinkedIn that functions as a conduit for information about the digital health business in Southern California, a forum for networking digital health stakeholders virtually, and a bully pulpit for digital health entrepreneurs ... Join the group
|
|
Stem Cell Research
|
$4 Million From Eli And Edythe Broad Foundation Will Support UCLA Research in Stem Cell
 FierceBiotech reports that "two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers. The gifts bring to $30 million The Broad Foundation's total support of faculty recruitment and basic and translational research at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and at the Center for Inflammatory Bowel Diseases at UCLA's Division of Digestive Diseases." ... Read more.
|
|
M&A
|
 | | David Pyott, Chairman, Allergan |
Allergan Rebuffs Valeant's Takeover Bid
Allergan formally rejected a $46bn unsolicited takeover bid made by Valeant on Monday, saying the proposal substantially undervalues the Botox maker.In a press release, Allergan casts dobts on the sustainability of Valeant's business model ... Read Press Release
Also read:
|
| Jobs ... Jobs ... jobs |
Kite Pharma (Santa Monica)
KGI (Claremont)
ImaginAB (Ingelwood)
BIOLASE (Irvine)
C3 Jian (Los Angeles)
Gilead (San Dimas)
Gilead (Oceanside)
Quantimetrix (Redondo Beach)
Click here for more info and to apply
- R&D Associate
- Sales Representative
- Distribution Associate
- Advertising Assistant
- Customer Service Representative (P/T)
Bioness (Santa Clarita)
Allvivo Vascular (Lake Forest)
Bench International (Los Angeles)
Inogen (Goleta)
Carolina Liquid Chemistries
(Winston Salem, NC and Brea, Calif.)
Applied Biocode (Santa Fe Springs)
ADRx (Thousand Oaks)
Presbia (Irvine)
Second Sight Medical Products (Sylmar)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
